Overall rank by patents
#24,544
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G11B (INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER).
The verdict
According to USPTO PatentsView, Infinitum ranks #24,544 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R24544 · US Corporation #24,544 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Incarda Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
3-D Matrix · near
38 score
ECM · near
38 score
Infinitum Solutions · this assignee
38 score
Ultrata · near
38 score
University College D… · near
38 score
3D Lighting Innovati… · lowest
7 score
What this shows Infinitum's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Infinitum Solutions, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 72.7% of grants classified under G11B (INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2018. By volume, Infinitum sits between Incarda Therapeutics, Inc. and Innovital, Llc.
Infinitum Solutions, Inc. shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
InCarda Therapeutics, Inc.
11 patents
Indian Ocean Medical Inc.
11 patents
Indorma Ventures Oxides LLC
11 patents
Industrilås i Nässjö Aktiebolag
11 patents
Information Resources, Inc.
11 patents
Inhibrx Biosciences, Inc.
11 patents
Inkron Oy
11 patents
InnoVital, LLC
11 patents
Infinitum Solutions, Inc.
11 patents
What this shows Infinitum holds 11 patents at rank #24,554, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,554 in granted patent volume.
Other assignees with the most granted patents in Infinitum's primary technology class.
Two PlainPatent-derived peer sets for Infinitum, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (38 here).
Infinitum's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 4 | 36.4% |
| 2017 | 3 | 27.3% |
| 2018 | 1 | 9.1% |
| 2022 | 1 | 9.1% |
Top 5 of 5 technology areas
Overall rank by patents
#24,544
of 50,000 tracked assignees
38.2 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.